GlassScriptPhysician profile
Thomas F Laney
NPI 1891753687
$4,864.98
in general payments reported to CMS, 2019-2025
40 companies · $709 in 2025
The $709 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $756 · 2021: $702 · 2022: $775 · 2023: $631 · 2024: $498 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $931.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $697.09 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $482.13 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $264.32 | 2021-2025 | |
| Amgen INC. | $244.57 | 2019-2025 | Evenity, Prolia, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.36 | 2019-2025 | Jardiance |
| Pfizer INC. | $190.60 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $155.98 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $141.68 | 2019-2021 | |
| Abbott Laboratories | $138.71 | 2022-2025 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $109.51 | 2021-2023 | |
| Kaleo, INC. | $107.24 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $102.81 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $92.87 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $85.58 | 2019-2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Laney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.